Paraplatin (carboplatin) is a small molecule pharmaceutical. Carboplatin was first approved as Paraplatin on 1989-03-03. It is used to treat bone marrow diseases, breast neoplasms, central nervous system neoplasms, endometrial neoplasms, and esophageal neoplasms amongst others in the USA.
|Indication||bone marrow diseases, breast neoplasms, central nervous system neoplasms, endometrial neoplasms, esophageal neoplasms, germ cell and embryonal neoplasms, lung neoplasms, osteosarcoma, ovarian neoplasms, urinary bladder neoplasms|
|Drug Class||Antineoplastics (platinum derivatives)|